Infanrix IPV + Hib inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial

Land: Belgien

Språk: engelska

Källa: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktiva substanser:

Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose; Bordetella Pertussis Pertactin 8 µg/dose; Tetanus Toxoid >= 40 IU/dose; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Diphtheria Toxoid (DT) >= 30 IU/dose; Conjugate of Haemophilus influenzae type b capsular polysaccharide and Tetanus toxoid

Tillgänglig från:

GlaxoSmithKline Biologicals SA-NV

ATC-kod:

J07CA06

INN (International namn):

Diphteria Antigen, Adsorbed; Haemophilus Influenzae Type b Polysaccharides, conjugated to tetanus toxoid; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Läkemedelsform:

Powder and solvent for suspension for injection

Sammansättning:

Diphteria Antigen, Adsorbed; Haemophilus Influenzae Type b Polysaccharides, conjugated to tetanus toxoid; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Administreringssätt:

Intramuscular use

Terapiområde:

Diphtheria-Hemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus

Produktsammanfattning:

CTI code: 193961-01 - Pack size: 1 dose + 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Bemyndigande status:

Commercialised: No

Tillstånd datum:

1998-07-15